Tieron / Targeting
Annual report 2026-03-25
Companies › Japanese listed company

CHUGAI PHARMACEUTICAL CO., LTD.

中外製薬株式会社Tokyo Stock Exchange 4519, Pharmaceutical. Supply-chain directory entry built from public EDINET filings, including relationships the company disclosed in its own annual securities report.

COMPANY NAME (JP)
中外製薬株式会社
TICKER
TSE 4519
EDINET CODE
E00932
CORPORATE NUMBER
5011501002900
INDUSTRY
Pharmaceutical (医薬品)
HEAD OFFICE
北区浮間五丁目5番1号
DISCLOSED FOOTPRINT
7 sites · 15 subsidiaries

Disclosed major customers

Counterparties CHUGAI PHARMACEUTICAL CO., LTD. named in its own annual securities report. A company named here has CHUGAI PHARMACEUTICAL CO., LTD. in its supply base.

エフ・ホフマン・ラ・ロシュ・リミテッド57.6% of revenue
エフ・ホフマン・ラ・ロシュ・リミテッド | 724,053百万円(57.6%)
Annual securities report (有価証券報告書), filed 2026-03-25 — EDINET S100XTBJ
アルフレッサ ホールディングス株式会社及びそのグループ会社12.1% of revenue
アルフレッサ ホールディングス株式会社及びそのグループ会社 | 152,292百万円(12.1%)
Annual securities report (有価証券報告書), filed 2026-03-25 — EDINET S100XTBJ

Business segments

医薬品事業
100% of revenue新規の医療用医薬品の研究、開発、製造、販売活動
The filing addresses human rights and partially describes human-rights due diligence: “その中でも、サステナビリティに関するリスクとしては、制度・規制・政策に関連するリスク、ITセキュリティ・情報管理に関するリスク、大規模災害、サプライチェーン、パンデミックなどの外部環境の動向に左右される事項、ならびに人権や地球環境問題などの企業市民としての社会的責任が大きい事項について、注視して取り組んでいます。

Sector risk context: supply-chain risk by country and sector.

More Pharmaceutical companies

DAIICHI SANKYO COMPANY, LIMITEDEisai Co., Ltd.Takeda Pharmaceutical Company LimitedAnGes, Inc.ASKA Pharmaceutical Holdings CO., Ltd.BrightPath Biotherapeutics Co., Ltd.CanBas Co.,Ltd.Carna Biosciences, Inc.
Screening CHUGAI PHARMACEUTICAL CO., LTD. or mapping suppliers like them? Check any company against sanctions and forced-labor lists, free.Free sanctions check →

Work at CHUGAI PHARMACEUTICAL CO., LTD.? Claim this page to review the data your customers see.

Get sanctions & UFLPA list updates
A short note when the lists change in ways that matter for supply-chain screening. No noise.
Sources: EDINET code list (Financial Services Agency) and the company’s own annual securities report (有価証券報告書) retrieved via EDINET. Disclosed relationships are quoted from the filing and carry its EDINET accession number; extraction is automated and conservative — anything the filing does not state is left out. Tieron does not certify, audit or endorse the company, and this page contains no Tieron risk assessment. Report an issue with this page — corrections referencing the accession number shown above are fastest to verify.
CHUGAI PHARMACEUTICAL CO., LTD. — suppliers, customers & supply chain profile · Tieron